GlaxoSmithKline's Flonase goes OTC in US

28 July 2014 - Deborah Wilkes

Archived

GlaxoSmithKline plans to launch Flonase Allergy Relief into the US OTC market in early 2015, after the Food and Drug Administration (FDA) approved the once-a-day nasal spray containing fluticasone propionate as an OTC medicine.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: